Sonnet BioTherapeutics (SONN) to Release Quarterly Earnings on Monday

Sonnet BioTherapeutics (NASDAQ:SONN – Get Free Report) will post its quarterly earnings results on Monday, February 12th. Sonnet BioTherapeutics Stock Up 2.7 % NASDAQ SONN opened at $1.51 on Friday. Sonnet BioTherapeutics has a one year low of $1.08 and a one year high of $26.40. The business has a 50 day simple moving average […]

Related Keywords

,Renaissance Technologies ,Geode Capital Management ,Sonnet Biotherapeutics Company Profile ,Sabby Management ,Sonnet Biotherapeutics Holdings Inc ,Get Free Report ,Funds Management ,Capital Management ,Sonnet Biotherapeutics ,Nasdaq Sonn ,Sonn ,Medical ,Earnings ,